Methyl 3-(5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl)benzoate, 97.0%, 250mg

E-Plan phase EPLPHi S100x/1.25 oil immersion infinity corrected IOS objective. Working distance 0.36 mm

(4-(Methyl(phenyl)carbamoyl)phenyl)boronic acid, 97%, 25g

2-Bromoisonicotinamide, 95.0%, 25g

4-(Trifluoromethoxy)phenoxyacetyl chloride, 5g

trans-4-(Aminomethyl)cyclohexanecarboxylic acid, 98.0%, 5g

FTAXILIDE, 98%, 5mg

Mycophenolic Acid, >98%, 25g

Z-D-Leu-ONp, 95.0%, 25g

3-Methoxy-2-methylaniline, 97.0%, 10g

Ammonium sulphide solution, 20%, pure, 500 ml, plastic bag.

3-Fluoro-N1,N1-dimethylbenzene-1,4-diamine, 95+%, 250mg

2-Iodo-4-(trifluoromethyl)benzoic acid, 98.0%, 25g